MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 4933-4942

  Tian, Xiaoying ^a,b   Xu, Limian ^b   Wang, Peng ^c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

DAPK1; EAOC; Endometriosis; miR 191

Indexed keywords

DAPK1 PROTEIN, HUMAN; DEATH ASSOCIATED PROTEIN KINASE; MESSENGER RNA; MICRORNA; MIRN191 MICRORNA, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; APOPTOSIS; CASE CONTROL STUDY; CELL TRANSFORMATION; DRUG EFFECTS; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; APOPTOSIS; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DEATH-ASSOCIATED PROTEIN KINASES; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MICRORNAS; MIDDLE AGED; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937837370     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ and Bristow RE. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. Cancer 2003; 98: 1658-1663.
2. Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO and del Carmen MG. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome. J Reprod Med 2013; 58: 469-476.
3. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A; Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394.
4. Kim HS, Kim TH, Chung HH and Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 2014; 110: 1878-1890.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
6. Braza-Boils A, Mari-Alexandre J, Gilabert J, Sanchez-Izquierdo D, Espana F, Estelles A and Gilabert-Estelles J. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod 2014; 29: 978-988.
7. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP and Huang X. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19: 1213-1224.
8. Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen HS, Chang Y, Chuang HY, Lee JN, Hsu YL and Tsai EM. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol 2014; 232: 330-343.
9. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW and Kim S. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008; 14: 2690-2695.
10. Prefumo F, Venturini PL and Fulcheri E. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis. Int J Gynecol Pathol 2003; 22: 83-88.
11. Teague EM, Print CG and Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010; 16: 142-165.
12. Shen J, DiCioccio R, Odunsi K, Lele SB and Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer 2010; 10: 47.
13. Nagpal N and Kulshreshtha R. miR-191: an emerging player in disease biology. Front Genet 2014; 5: 99.
14. Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH and Dey SK. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 2008; 68: 5619-5627.
15. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008; 68: 425-433.
16. Panda H, Pelakh L, Chuang TD, Luo X, Bukulmez O and Chegini N. Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKbeta, KLF9, and FBLN5. Reprod Sci 2012; 19: 786-796.
17. Wu B, Yao H, Wang S and Xu R. DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-kappaB, and caspase-3 activation. Biochem Biophys Res Commun 2013; 434: 75-80.
18. Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG and Marine JC. dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 2005; 24: 1461-1466.
19. Lin Q, Geng J, Ma K, Yu J, Sun J, Shen Z, Bao G, Chen Y, Zhang H, He Y, Luo X, Feng X and Zhu J. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol 2009; 135: 1675-1684.
20. Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, Camargo AA, Caballero OL, Tajara EH, Cordeiro JA and Rahal P. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 2007; 173: 31-37.
21. Missaoui N, Hmissa S, Trabelsi A, Traore C, Mokni M, Dante R and Frappart L. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 2011; 207: 37-42.
22. Yoo HJ, Byun HJ, Kim BR, Lee KH, Park SY and Rho SB. DAPk1 inhibits NF-kappaB activation through TNF-alpha and INF-gamma-induced apoptosis. Cell Signal 2012; 24: 1471-1477.